A new study has found that AI chatbots habitually recommend alternative cancer treatments to chemotherapy, potentially putting lives at risk.
A team from the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center tested a series of widely used bots as part of their research, including xAI’s Grok, OpenAI’s ChatGPT, Google’s Gemini, Meta’s AI, and High-Flyer’s DeepSeek.